163 related articles for article (PubMed ID: 33082557)
1. Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation.
Zhang Q; Zhou W; Yu S; Ju Y; To SKY; Wong AST; Jiao Y; Poon TCW; Tam KY; Lee LTO
Oncogene; 2021 Jan; 40(1):97-111. PubMed ID: 33082557
[TBL] [Abstract][Full Text] [Related]
2. TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer.
Gao C; Yao H; Liu H; Feng Y; Yang Z
BMC Cancer; 2019 Mar; 19(1):237. PubMed ID: 30876464
[TBL] [Abstract][Full Text] [Related]
3. ACSL1-Mediated Fatty Acid β-Oxidation Enhances Metastasis and Proliferation in Endometrial Cancer.
Zhou Y; Li Y; Chen G; Guo X; Gao X; Meng J; Xu Y; Zhou N; Zhang B; Zhou X
Front Biosci (Landmark Ed); 2024 Feb; 29(2):66. PubMed ID: 38420815
[TBL] [Abstract][Full Text] [Related]
4. PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming.
Feng Y; Tang Y; Mao Y; Liu Y; Yao D; Yang L; Garson K; Vanderhyden BC; Wang Q
Int J Oncol; 2020 Mar; 56(3):697-708. PubMed ID: 31922217
[TBL] [Abstract][Full Text] [Related]
5. BTB and CNC homology 1 (Bach1) promotes human ovarian cancer cell metastasis by HMGA2-mediated epithelial-mesenchymal transition.
Han W; Zhang Y; Niu C; Guo J; Li J; Wei X; Jia M; Zhi X; Yao L; Meng D
Cancer Lett; 2019 Mar; 445():45-56. PubMed ID: 30654010
[TBL] [Abstract][Full Text] [Related]
6. NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer.
Zhu J; Wu G; Song L; Cao L; Tan Z; Tang M; Li Z; Shi D; Zhang S; Li J
EBioMedicine; 2019 May; 43():238-252. PubMed ID: 31047858
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.
Ladanyi A; Mukherjee A; Kenny HA; Johnson A; Mitra AK; Sundaresan S; Nieman KM; Pascual G; Benitah SA; Montag A; Yamada SD; Abumrad NA; Lengyel E
Oncogene; 2018 Apr; 37(17):2285-2301. PubMed ID: 29398710
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
Mukherjee A; Chiang CY; Daifotis HA; Nieman KM; Fahrmann JF; Lastra RR; Romero IL; Fiehn O; Lengyel E
Cancer Res; 2020 Apr; 80(8):1748-1761. PubMed ID: 32054768
[TBL] [Abstract][Full Text] [Related]
9. HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis.
Li X; Zhang NX; Ye HY; Song PP; Chang W; Chen L; Wang Z; Zhang L; Wang NN
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(10):4126-4135. PubMed ID: 31173282
[TBL] [Abstract][Full Text] [Related]
10. An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis.
Zhao L; Ji G; Le X; Luo Z; Wang C; Feng M; Xu L; Zhang Y; Lau WB; Lau B; Yang Y; Lei L; Yang H; Xuan Y; Chen Y; Deng X; Yi T; Yao S; Zhao X; Wei Y; Zhou S
Oncogene; 2017 Jun; 36(24):3384-3396. PubMed ID: 28114283
[TBL] [Abstract][Full Text] [Related]
11. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
[TBL] [Abstract][Full Text] [Related]
12. Proteomics to Predict Loss of RXR-γ During Progression of Epithelial Ovarian Cancer.
Kalra RS; Bapat SA
Methods Mol Biol; 2019; 2019():1-14. PubMed ID: 31359385
[TBL] [Abstract][Full Text] [Related]
13. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
Li N; Gou JH; Xiong J; You JJ; Li ZY
BMC Cancer; 2020 Mar; 20(1):222. PubMed ID: 32178630
[TBL] [Abstract][Full Text] [Related]
14. Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice.
Goldenberg JR; Wang X; Lewandowski ED
J Mol Cell Cardiol; 2016 May; 94():1-9. PubMed ID: 26995156
[TBL] [Abstract][Full Text] [Related]
15. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
Li H; Zhang W; Niu C; Lin C; Wu X; Jian Y; Li Y; Ye L; Dai Y; Ouyang Y; Chen J; Qiu J; Song L; Zhang Y
Int J Cancer; 2019 Oct; 145(7):1921-1934. PubMed ID: 30895619
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells.
Senga S; Kobayashi N; Kawaguchi K; Ando A; Fujii H
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1057-1067. PubMed ID: 29906613
[TBL] [Abstract][Full Text] [Related]
17. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
Xu JH; Wang Y; Xu D
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
[TBL] [Abstract][Full Text] [Related]
18. FAM83D promotes ovarian cancer progression and its potential application in diagnosis of invasive ovarian cancer.
Zhang Q; Yu S; Lok SIS; Wong AST; Jiao Y; Lee LTO
J Cell Mol Med; 2019 Jul; 23(7):4569-4581. PubMed ID: 31037837
[TBL] [Abstract][Full Text] [Related]
19. Defective fatty acid oxidation in mice with muscle-specific acyl-CoA synthetase 1 deficiency increases amino acid use and impairs muscle function.
Zhao L; Pascual F; Bacudio L; Suchanek AL; Young PA; Li LO; Martin SA; Camporez JP; Perry RJ; Shulman GI; Klett EL; Coleman RA
J Biol Chem; 2019 May; 294(22):8819-8833. PubMed ID: 30975900
[TBL] [Abstract][Full Text] [Related]
20. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
